# A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

> **NCT01093118** · PHASE2 · TERMINATED · sponsor: **Talima Therapeutics, Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Distal Subungual Onychomycosis

## Interventions

- **DRUG:** TMI-358
- **DRUG:** MMI-467

## Key facts

- **NCT ID:** NCT01093118
- **Lead sponsor:** Talima Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** Business decision
- **Last updated:** 2011-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093118, "A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01093118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*